QUOTE AND NEWS
Business Wire  May 9  Comment 
Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) today announced operating and financial results for the three months ended March 31, 2012, and provided an update on the Company’s key business initiatives.
Business Wire  May 4  Comment 
Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced today that it will host a conference call to discuss first quarter 2012 operating and financial results on Wednesday, May 9, 2012 at 9:00 a.m. Eastern
StreetInsider.com  Apr 10  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/EpiCept+%28EPCT%29+Gets+FDA+Fast+Track+Designation+for+AmiKet/7333102.html for the full story.
Business Wire  Apr 4  Comment 
Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced today that new preclinical research for its apoptosis inhibitor drug candidate EP1013 (now renamed F573) has concluded that F573 is a new therapeutic drug
Business Wire  Mar 29  Comment 
Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced today that it has entered into a definitive agreement with a single life science focused institutional investor for the purchase of 1,065 shares of its new
Benzinga  Jan 24  Comment 
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) today confirmed that its engagement of SunTrust Robinson Humphrey to assist in exploring strategic alternatives to maximize the commercial opportunity of AmiKet™ includes the...
StreetInsider.com  Sep 12  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/EpiCept+%28EPCT%29+Updates+on+Ceplene+Progress%3B+Recently+Met+with+FDA+for+Additional+Guidance/6776649.html for the full story.
StreetInsider.com  Aug 29  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/EpiCept+%28EPCT%29+Files+%2425M+Common+Shelf/6747255.html for the full story.
StreetInsider.com  Aug 15  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/EpiCept+Corporation+%28EPCT%29+Reports+Q2+EPS+Loss+of+%240.06/6714292.html for the full story.
StreetInsider.com  Jul 18  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/EpiCept%27s+%28EPCT%29+IL-2+Not+Effective+as+AML+Maintenance+Treatment%3B+New+Data+Published/6641855.html for the full story.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki